Patent details

Basic Information

Publication number:

EP1928490

PCT Application Number:

PCT/US/2006/037554

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP068155050

PCT Publication Number:

WO/2007/038548

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS AND METHODS OF USING CHONDROITINASE ABCI MUTANTS

French Title of Invention:

COMPOSITIONS ET PROCEDES D'UTILISATION DE MUTANTS DES CHONDROITINASES ABCI

German Title of Invention:

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON CHONDROITINASE-ABCI-MUTANTEN

SPC Number:

Dates

Filing date:

26/09/2006

Grant date:

29/08/2012

EP Publication Date:

29/08/2012

PCT Publication Date:

05/04/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/06/2008

EP B1 Publication Date:

29/08/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/09/2012

Expiration date:

26/09/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/09/2012

 

 

Name:

Acorda Therapeutics Inc.

Address:

420 Saw Mill River Road, Ardsley, NY 10502, United States (US)

Inventor

1

Name:

IACI Jennifer

Address:

United States (US)

2

Name:

CAGGIANO Anthony, O.

Address:

United States (US)

3

Name:

VECCHIONE Andrea

Address:

United States (US)

4

Name:

MARKENSOHN Elizabeth

Address:

United States (US)

Priority

Priority Number:

720628 P

Priority Date:

26/09/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 9/00;